Distributions of five common point mutants in the human tracheal-bronchial epithelium
- PMID: 16458330
- DOI: 10.1016/j.mrfmmm.2005.12.008
Distributions of five common point mutants in the human tracheal-bronchial epithelium
Abstract
The mutations C742T, G746T, G747T in the TP53 gene and G35T in the KRAS gene have been repeatedly found in sectors of human tumors by direct DNA sequencing. The mutation G508A in the HPRT1 gene has been repeatedly found among peripheral T lymphocytes by clonal expansion under selective conditions. To discover if these mutations also occur frequently in normal tissues from which tumors arise, we have developed and validated allele-specific mismatch amplification mutation assays (MAMA) for each mutation. Reconstruction experiments demonstrated linearity in the range of 9-3000 mutant alleles among 3 x 10(6) wild-type alleles. The cumulative distributions of all negative controls established robust detection limits (P<0.05) of 34-125 mutants per 10(6) copies assayed depending on the mutation. One hundred and seventy-seven micro-anatomical samples of approximately (0.5-6)x10(6) tracheal-bronchial epithelial cells from nine non-smokers were assayed representing en toto the equivalent of approximately 1.6 human bronchial trees to the fifth bifurcation. Statistically significant mutant copy numbers were found in 257 of 463 assays. Clusters of mutant copies ranged from 10 to 1000 in 239/257 positive samples. As all five point mutations were detected at mutant fractions of >10(-5) in two or more lungs, we infer that they are mutational hotspots generated in lung epithelial stem cells. As the cancer-associated mutations did not differ in cluster size distribution from the HPRT1 mutation, we infer that none of the mutations conferred a growth advantage to somatic heterozygous clusters or maintenance turnover units. Specific mutants appeared in very large copy numbers, 1000-35,000, in 18/257 positive assays. Various hypotheses to account for the observed cluster size distributions are offered.
Similar articles
-
Fetal-juvenile origins of point mutations in the adult human tracheal-bronchial epithelium: absence of detectable effects of age, gender or smoking status.Mutat Res. 2008 Nov 10;646(1-2):25-40. doi: 10.1016/j.mrfmmm.2008.08.016. Epub 2008 Sep 9. Mutat Res. 2008. PMID: 18824180
-
Single base instability is promoted in vulvar lichen sclerosus.J Invest Dermatol. 2007 Nov;127(11):2563-76. doi: 10.1038/sj.jid.5700889. Epub 2007 Jun 7. J Invest Dermatol. 2007. PMID: 17554370
-
Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.Cancer. 1997 Feb 15;79(4):700-16. Cancer. 1997. PMID: 9024708
-
The natural somatic mutation frequency and human carcinogenesis.Adv Cancer Res. 1997;71:209-40. doi: 10.1016/s0065-230x(08)60100-1. Adv Cancer Res. 1997. PMID: 9111867 Review.
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
Cited by
-
Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells.BMC Cancer. 2019 Nov 11;19(1):1081. doi: 10.1186/s12885-019-6313-x. BMC Cancer. 2019. PMID: 31711466 Free PMC article.
-
Analysis of mutational spectra by denaturing capillary electrophoresis.Nat Protoc. 2008;3(7):1153-66. doi: 10.1038/nprot.2008.79. Nat Protoc. 2008. PMID: 18600220 Free PMC article.
-
Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas.Environ Mol Mutagen. 2017 Aug;58(7):466-476. doi: 10.1002/em.22110. Epub 2017 Jul 29. Environ Mol Mutagen. 2017. PMID: 28755461 Free PMC article.
-
Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk.Environ Mol Mutagen. 2020 Jan;61(1):152-175. doi: 10.1002/em.22326. Epub 2019 Oct 6. Environ Mol Mutagen. 2020. PMID: 31469467 Free PMC article. Review.
-
Quantification of cancer driver mutations in human breast and lung DNA using targeted, error-corrected CarcSeq.Environ Mol Mutagen. 2020 Nov;61(9):872-889. doi: 10.1002/em.22409. Epub 2020 Sep 28. Environ Mol Mutagen. 2020. PMID: 32940377 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous